PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA Suspension
Country: Canada
Language: French
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Polystyrène sulfonate de sodium
Available from:
PHARMEL INC
ATC code:
V03AE01
INN (International Name):
POLYSTYRENE SULPHONATE
Dosage:
250MG
Pharmaceutical form:
Suspension
Composition:
Polystyrène sulfonate de sodium 250MG
Administration route:
Rectale
Units in package:
120ML
Prescription type:
Prescription
Therapeutic area:
POTASSIUM-REMOVING AGENTS
Product summary:
Numéro de groupe d'ingrédients actifs (GIA) :0108701001; AHFS:
Authorization status:
ANNULÉ APRÈS COMMERCIALISATION
Authorization date:
2010-11-25
